Goodwin Law

At Goodwin, we are a long-term partner to our clients and have deep experience supporting founders from company formation and initial fundraising through all financings, private and public, and liquidity events including secondaries, M&A, IPO & SPACs. With our focus on technology and life sciences, we are sector-focused and stage-agnostic.

  • Better Dairy
    • $22 million – Series B
  • Cleo
    • $80 million – Series C
  • Closed Loop Medicine
    • £13 million -Financing
  • Quanta Dialysis
    • £245 million – Series D
  • Vaccitech
    • £168 million – Series B
  • Mojo
    • $4.4 million – Seed
  • Selina
    • $150 million – Series B
  • Growth Kitchen
    • £3 million – Seed
  • Zapp
    • Undisclosed – Series B
  • Matillion
    • $150 million – Series E
  • Vivid Money
    • $114 million – Series C
  • Omnipresent
    • $11 million – Series A
  • Hopin
    • $450 million – Series D
  • Tranch
    • $4.25 million – Pre seed
  • MiroBio
    • $97 million – Series B
  • Evox Therapeutics
    • £69.2 million – Series C